Aurobindo Pharma becomes India's 2nd-biggest overtaking Dr Reddy's with ₹33,653cr
Business
Aurobindo Pharma just jumped ahead of Dr Reddy's to become India's second-biggest pharma company by revenue for 2025-26.
Its earnings hit ₹33,653 crore, boosted by strong sales in Europe.
Dr Reddy's, which posted ₹33,593 crore, now takes third place.
Dr Reddy's still highest profit ₹4,285cr
Even though Dr Reddy's slipped in revenue, it is still leading when it comes to profit: ₹4,285 crore in FY26 (financial year 2025-26) (though that's down 24%).
Aurobindo made ₹3,503 crore in net profit.
Sun Pharma stays at the top for overall revenue.
Both Hyderabad-based companies are gearing up with new products like biosimilars to keep their edge going forward.